TTNP 3.65 (-1.35%)
US8883146065BiotechnologyBiotechnology

Titan Pharmaceuticals (TTNP) Stock Highlights

3.65 | -1.35%
2024-11-21 06:39:26
Titan Pharmaceuticals Inc is a pharmaceutical company developing therapeutics utilizing its proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases for which steady state delivery of a drug provides efficacy and/or safety benefit. ProNeura consists of a small, solid implant made from a mixture of ethylene-vinyl acetate, or EVA, and a drug substance. Its first product based on ProNeura technology was the Probuphine (buprenorphine) implant, which was approved in the United States, Canada and the European Union, for the maintenance treatment of opioid use disorder in clinically stable patients taking 8 mg or less a day of oral buprenorphine.

Statistics

Range Today
3.57 3.95
Volume Today 15K
Range 1 Year
3.51 14.8
Volume 1 Year 29.86M
Range 3 Year
3.51 31.8
Volume 3 Year 34.49M
Range 10 Year
3.51 31464
Volume 10 Year 50.9M

Highlights

Market Capitalization 3.82M (micro)
Floating Shares 700.06K
Current Price 3.65
Price To Earnings -0.63
Price To Revenue -92.88
Price To Book 0.95
Earnings Per Share -6.62
Payout Ratio 0%

Performance

Latest -1.35%
1 Month -23.48%
3 Months -58.94%
6 Months -44.7%
1 Year -47.86%
3 Years -87.24%
5 Years -96.2%
10 Years -99.96%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.